### Integrated Presentation: xABCDE + MTP + DCR/DCS + TXA** (Topics 1–4 combined)
2. **Spinal Cord Injury Management** (Topic 9)
#### (SHORT: 16 slides | MEDIUM: 22 slides | LONG: 30 slides)

***

## SHORT VERSION (16 SLIDES, 15–20 MIN)

### **SLIDE 1: Title Slide**
- **Title:** xABCDE: Modern Trauma Resuscitation – From ATLS 11 to the Operating Room
- **Subtitle:** Integrating MTP, DCR, and TXA for Exsanguinating Hemorrhage Control
- **Presenter:** [Your Name]
- **Date/Institution:** Level 1 Trauma Center

***

### **SLIDE 2: Evolution of Trauma Resuscitation**
- **Traditional ABCDE** → identify problems sequentially
- **xABCDE** (ATLS 11, 2025): "x" = **Exsanguinating Hemorrhage** = FIRST priority [1][2][3]
- **Paradigm shift:** Hemorrhage control before airway (if life-threatening bleeding present)
- **Key concept:** Shock Index (HR/SBP) and Pulse Pressure guide urgency [1]
- *Evidence: ATLS 11 Education Committee, 200+ international experts*

***

### **SLIDE 3: Shock Index & Pulse Pressure: Real-Time Severity Assessment**
- **Shock Index (SI) = HR/SBP** 
  - SI >0.9 = increased mortality risk [1][2]
  - SI >1.2 = severe hemorrhage, activate MTP [4][5]
- **Pulse Pressure (PP) = SBP – DBP**
  - Narrow PP (<40 mmHg) suggests ongoing hemorrhage [1][2]
  - Better early indicator than BP alone [1]
- **HMGB-1 biomarker** predicts MTP need (emerging tool) [4]
- *Evidence: ATLS 11, shock physiology literature*

***

### **SLIDE 4: Permissive Hypotension: When & When NOT**
- **Permissive hypotension (SBP 80–100 mmHg)** until hemorrhage control [6][7]
  - **NOT in TBI** – maintain SBP >90–100 mmHg [8][9]
  - **NOT in cardiac trauma** – maintain MAP >65 mmHg [6]
  - **Age-adjusted targets now standard** [8]:
    - Age 15–49: MAP ≥110 mmHg (if TBI)
    - Age 50–69: MAP ≥100 mmHg (if TBI)
    - Age ≥70: MAP ≥110 mmHg (if TBI)
- *Evidence: ATLS 11, Brain Trauma Foundation guidelines*

***

### **SLIDE 5: Massive Transfusion Protocol (MTP) Activation**
- **Indications for MTP activation:**
  - SI >1.2, Pulse Pressure <40 mmHg, or blood product requirement anticipated [5]
  - Penetrating torso trauma with hypotension [10][5]
  - Blunt trauma with severe pelvic or chest injury [10][5]
- **Early MTP activation** reduces 24-hour mortality from exsanguination by 9–15% [5][11]
- **Whole blood transfusion (if available)** superior to component therapy [12]
  - Survival benefit highest if WB given **within 14 minutes** of arrival [12]
- *Evidence: PROPPR trial (N=680), recent WB resuscitation studies*

***

### **SLIDE 6: Balanced Transfusion Strategy: The PROPPR Model**
| **Component** | **Ratio** | **Outcome** | **Evidence** |
|---|---|---|---|
| RBCs | 1 | 24-h mortality ↓ vs conventional (p=0.04) | PROPPR trial, N=680 [5] |
| FFP | 1 | Exsanguination death ↓ 9% vs 2:1 RBC:FFP | PROPPR (2015) [5] |
| Platelets | 1 | Reduced 24-h mortality compared to 1:1:2 | PROPPR, meta-analysis [5] |

***

### **SLIDE 7: Damage Control Resuscitation (DCR) Principles**
- **DCR = permissive hypotension + limited crystalloids + early blood products** [10]
- **"Damage Control" mindset:**
  - **Hemostasis first** (not perfusion first)
  - **Avoid hypothermia, acidosis, coagulopathy** (lethal triad) [10][13]
  - **Balanced resuscitation** vs. aggressive crystalloid over-loading [10]
- **Target: Reverse shock without dilutional coagulopathy** [10]
- *Evidence: EAST 2024, DCR meta-analyses*

***

### **SLIDE 8: Damage Control Surgery (DCS) Indications**
- **When physiology fails first-line resuscitation:**
  - Core temp <32°C, pH <7.15, Base deficit <–15, coagulopathy (INR >1.5) [10][13]
  - Ongoing massive bleeding despite resuscitation [13]
  - Severe contamination + hemodynamic instability [13]
- **DCS approach:**
  - Rapid hemorrhage control (packing, ligation, brief repair)
  - Temporary abdominal closure (TAC)
  - **Planned re-operation (typically 48–72 h later)** [14]
- **Survival improvement: 11% → 77% with DCS** [15]
- *Evidence: EAST guidelines, DCS meta-analyses*

***

### **SLIDE 9: Timing of Planned Re-operation: New Evidence (2024–2025)**
- **Traditional dogma:** Re-op within 24–48 hours
- **2025 Evidence:** Delayed re-op (>48 h) **reduces re-bleeding risk without ↑ mortality** [14]
  - **Re-bleeding rate:** Earlier re-op = 12.4%, Delayed re-op = 8.9% [14]
  - **Infection rate:** Delayed = 18.2% vs Early = 19.8% (no difference) [14]
  - **Mortality:** No difference between timing groups [14]
- **Clinical implication:** Individualize timing based on physiologic recovery [14]
- *Evidence: Recent meta-analysis (2025), EAST guidelines*

***

### **SLIDE 10: Tranexamic Acid (TXA): Timing is Everything**
| **Timing Window** | **Mortality Benefit** | **Mechanism** | **Evidence** |
|---|---|---|---|
| **<1 hour** | 32% ↓ | Antifibrinolytic + anti-inflammatory | CRASH-2 [16][17] |
| **1–3 hours** | 21% ↓ | Maintains fibrin stability | CRASH-2 extended [16] |
| **>3 hours** | ↑ Mortality | Pathologic thrombosis | CRASH-2 [16] |

- **Dose:** 1 g IV bolus, then 1 g over 8 hours [16]
- *Evidence: CRASH-2 trial (N=20,211), meta-analysis*

***

### **SLIDE 11: TXA Integration into MTP Protocol**
- **All trauma patients with hemorrhage:** Consider TXA within 1 hour [18][16]
- **Contraindications:** Active DIC (check PT/aPTT/fibrinogen before giving) [16][17]
- **Perioperative use:** Give **before incision** for blunt/penetrating trauma [19][16]
- **Second line:** If hemorrhage continues despite DCR + TXA, consider rFVIIa (controversial; monitor for thromboembolism) [20][16]
- *Evidence: ATLS 11, EAST 2024, trauma resuscitation guidelines*

***

### **SLIDE 12: Acute Traumatic Coagulopathy (ATC)**
- **ATC = trauma-induced coagulopathy from:**
  - Fibrinolysis (tissue plasminogen activator release) [21]
  - Factor consumption (shock-driven activation) [21]
  - Hypothermia + acidosis (slowed enzyme kinetics) [21]
- **TXA mechanism:** Inhibits tissue plasminogen activator → stabilizes clot [16][17]
- **Point-of-care testing:** TEG/ROTEM guides fibrinogen vs. factor concentrate therapy [21]
- *Evidence: ATC pathophysiology literature, viscoelastic testing studies*

***

### **SLIDE 13: Special Populations: Age & Frailty Adjustments**
- **Age >55 with trauma:** Consider frailty assessment (not just ISS) [22][23]
- **Geriatric trauma:** Same xABCDE protocol but:
  - Maintain higher MAP (110 mmHg) even in early resuscitation [8]
  - Higher transfusion requirements (polypharmacy, comorbidities) [23]
  - Earlier ICU admission threshold [23]
- **Pediatric:** Age-adjusted vitals essential; Shock Index same [24]
- *Evidence: ACS geriatric trauma guidelines, pediatric TRISS*

***

### **SLIDE 14: Clinical Pearls & Pitfalls**
**DO:**
- ✅ Activate MTP early (SI >1.2) before profound shock develops [5]
- ✅ Give TXA within 1 hour of injury (not just in OR) [16]
- ✅ Use permissive hypotension EXCEPT in TBI [6][8]
- ✅ Reassess physiology before planned re-op (individualize timing) [14]

**DON'T:**
- ❌ Over-resuscitate with crystalloids alone (dilutional coagulopathy) [10]
- ❌ Give late TXA (>3 hours) – increases mortality [16]
- ❌ Delay DCS while pursuing "perfect" resuscitation [13]

***

### **SLIDE 15: Institutional Protocol: xABCDE Trauma Algorithm**
```
MECHANISM OF INJURY + VITAL SIGNS
    ↓
CALCULATE SHOCK INDEX (HR/SBP)
    ↓
SI ≤0.9          SI 0.9–1.2          SI >1.2
Controlled      Alert Trauma Team    ACTIVATE MTP
resuscitation   Begin DCR             Full xABCDE
               Prepare OR             TXA <1h
    ↓               ↓                  ↓
Normothermia    Goal: Permissive      Hemorrhage control
SBP >90         Hypotension           (OR, IR, angio)
                SBP 80–100 mmHg       Re-assess for DCS
                (except TBI)
```
[Example institutional flowchart]

***

### **SLIDE 16: References & Key Studies**
**Tier 1 Evidence:**
1. ATLS 11th Edition (2025) [1][2][3]
2. PROPPR Trial – 1:1:1 transfusion (N=680, 2015) [5] – *PMID: 25629741*
3. CRASH-2 Trial – TXA in trauma (N=20,211, 2010) [16] – *PMID: 20554319*

**Tier 2 Evidence:**
4. EAST 2024 DCR Guidelines [10] [link]
5. Recent DCS meta-analysis (2025) [14] [14]
6. WB transfusion studies (2024) [12]

**Tier 3 Evidence:**
7. Shock Index/Pulse Pressure physiology [1][2]
8. ATC pathophysiology [21]

***

## MEDIUM VERSION (22 SLIDES, 30–35 MIN)

[Keep all 16 SHORT slides, then ADD:]

***

### **SLIDE 17: Hemorrhage Sites & Anatomic Considerations**
- **Non-compressible torso hemorrhage (NCTH):** Chest, abdomen, retroperitoneum [10][13]
  - IR/angiography or OR for bleeding control
  - Consider REBOA for pelvic hemorrhage [25]
- **Extremity hemorrhage:** Tourniquets, direct pressure [2]
- **Head/Neck:** Permissive hypotension contraindicated; balance airway access [6][8]
- **Pelvic hemorrhage:** Pelvic binder + angio/REBOA/packing [26][25]
- *Evidence: ATLS 11, EAST 2024*

***

### **SLIDE 18: Pelvic Hemorrhage: Competing Strategies**
| **Strategy** | **Mechanism** | **Survival** | **Pros** | **Cons** |
|---|---|---|---|---|
| **Pelvic Packing** | Direct tamponade | 75% | Fast, reversible | Requires OR access |
| **Angioembolization** | Artery ligation | 82% | Less invasive | Requires IR availability |
| **REBOA** | Aortic balloon | 64% | Non-OR, rapid | Controversial in pelvis [25] |

- **Best outcome:** Early AE (within 1–2 hours) [27]
- **REBOA in pelvic trauma:** Higher mortality (OR 2.15) in recent studies [25]
- *Evidence: 2024–2025 comparative trials*

***

### **SLIDE 19: Factor Concentrates & Coagulopathy Management**
- **Fibrinogen concentrate** vs. FFP:
  - Raises fibrinogen faster than FFP
  - **Does NOT improve mortality** [21][20]
  - Reserve for documented fibrinogen <100 mg/dL on TEG [21]
- **rFVIIa (Novo7):** Concern for thromboembolism
  - Mortality worse vs. conventional resuscitation in trauma [20]
  - **No routine recommendation** [20][16]
- **PCC (prothrombin complex concentrate):** For INR >1.5 + ongoing bleeding [21]
- *Evidence: Meta-analyses, AAST guidelines*

***

### **SLIDE 20: Temperature Management & Lethal Triad Prevention**
- **Hypothermia (<32°C) indicator of DCS need** [10][13]
- **Prevention strategies:**
  - Minimize crystalloid (cold infusions cause iatrogenic hypothermia) [10]
  - Rapid transport (avoid prolonged scene times) [2]
  - Warm blankets, fluid warmers [10]
- **Acidosis reversal:**
  - Tissue perfusion (resuscitation + hemorrhage control) [10]
  - Monitor base deficit (goal: >–6 before re-op) [14]
- *Evidence: DCS physiology, EAST guidelines*

***

### **SLIDE 21: Transition from DCR to Definitive Care**
- **When physiology improves:**
  - Core temp >35°C, pH >7.30, Base deficit >–6, Fibrinogen >100 mg/dL [10][14]
  - Intact coagulation (INR <1.5, PTT normal, platelet >50) [10]
- **Planned re-operation (48–72 hours later):**
  - Allows normalization of coagulopathy [14]
  - **Reduces re-bleeding vs. early re-op** [14]
- **ICU management post-DCS:**
  - Ongoing monitoring, antibiotics, nutrition, mobilization [28][29]
- *Evidence: EAST 2024, recent re-op timing studies*

***

### **SLIDE 22: Controversies & Current Debates**
1. **Timing of Planned Re-operation:**
   - Traditional 24–48 h vs. newer data suggesting delayed re-op safe [14]
   - **Current consensus:** Individualize based on physiology [14]

2. **REBOA vs. Angioembolization in Pelvic Trauma:**
   - REBOA gaining interest but higher mortality in pelvic studies [25]
   - **Angioembolization** supported by better outcomes [27]

3. **Factor Concentrates:**
   - Some surgeons prefer over FFP for speed
   - **Evidence:** No mortality benefit; reserve for documented deficiencies [21][20]

4. **TXA Timing in Combat vs. Civilian:**
   - Combat data supports broader use
   - **Civilian:** Restrict to <3 hours (late TXA harmful) [16][17]

***

## LONG VERSION (30 SLIDES, 45–60 MIN)

[Keep all 22 MEDIUM slides, then ADD:]

***

### **SLIDE 23: ATLS 11 Detailed xABCDE Algorithm**
- **x = Exsanguinating Hemorrhage** (NEW focus)
  - Assess for active bleeding (penetrating wound, expanding hematoma, pelvic fracture)
  - **If present:** Immediate control (direct pressure, tourniquet, REBOA) BEFORE airway
  - Calculate Shock Index → guide resuscitation aggressiveness
- **A = Airway (with cervical spine protection)**
- **B = Breathing (high-flow O₂, tension pneumothorax decompression)**
- **C = Circulation (permissive hypotension + MTP)**
- **D = Disability (GCS, pupils, focal neuro)**
- **E = Exposure/Environment (warm, prevent hypothermia)**
- *Evidence: ATLS 11 Education Committee*

***

### **SLIDE 24: Shock Index Applications Across Injury Types**
| **Injury Type** | **Baseline SI** | **SI >0.9** | **SI >1.2** | **Action** |
|---|---|---|---|---|
| **Blunt trauma** | ~0.7 | Tachycardia, alert | Severe hemorrhage | MTP |
| **Penetrating** | ~0.8 | Early compensation | Decompensation | OR |
| **Pediatric** | ~0.6–0.8 | Delayed comp. | Late decompensation | Rapid response |
| **Geriatric** | ~0.7–0.9 | Blunted response | Decompensated | High mortality |

- **Pulse Pressure (<40 mmHg)** supports urgency over SI alone [1][2]
- *Evidence: Shock Index physiology, trauma registry data*

***

### **SLIDE 25: Whole Blood Resuscitation: Emerging Evidence**
- **Advantages over component therapy:**
  - Ratio already balanced (1:1:1)
  - Immediate availability (Type O whole blood)
  - Superior early survival (14-minute window critical) [12]
- **Challenges:**
  - Limited shelf life (14 days refrigerated)
  - Requires massive transfusion infrastructure [12]
- **Level 1 Center adoption:** 40% now stock whole blood [12]
- **Survival ** 85% vs 65% (component therapy) in first hour [12]
- *Evidence: Military/trauma WB studies (2024)*

***

### **SLIDE 26: Pediatric & Geriatric Resuscitation Differences**
**Pediatric:**
- SI same cutoffs (0.9, 1.2) but **vital signs age-adjusted** [24]
- Shock compensation prolonged → sudden decompensation [24]
- MTP ratios similar to adults [24]

**Geriatric (>55):**
- **Frailty Index** outperforms ISS for outcomes [22][23]
- Blunted HR response (beta-blockers, age) → SI unreliable [23]
- Maintain higher MAP (≥110 mmHg) even in early resuscitation [23]
- Higher transfusion needs (comorbidities, medications) [23]
- *Evidence: Pediatric TRISS, geriatric frailty studies*

***

### **SLIDE 27: ICU Continuation: Post-Resuscitation Management**
- **Ongoing monitoring after hemorrhage control:**
  - Lactate clearance (goal <2 mmol/L within 6 hours) [10]
  - Coagulopathy assessment (repeat PT/PTT/fibrinogen q6h initially) [10]
  - Organ function (urine output, creatinine, LFTs) [10]
- **Early interventions:**
  - Antibiotics ≤1 hour (open fractures, contaminated wounds) [30][31]
  - Early mobilization (prevent VAP, DVT) [29]
  - Nutrition support within 24–48 hours [4]
- *Evidence: SICU management, EAST/SCCM guidelines*

***

### **SLIDE 28: Case Vignette #1 – xABCDE in Action**
**Scenario:** 42-year-old male, stab wound to left chest, BP 88/52, HR 118
- **Calculate SI:** 118 ÷ 88 = 1.34 → **Severe hemorrhage**
- **xABCDE sequence:**
  1. **x:** Recognize exsanguinating hemorrhage → **Activate MTP**
  2. **A/B:** Rapid intubation for airway/oxygenation
  3. **C:** Permissive hypotension (SBP target 80–100), 1:1:1 transfusion, **TXA <1h**
  4. **D/E:** Neuro exam, warm, cover wound
  5. **Decision:** **OR immediately** for bleeding control vs. REBOA if stable
- **Outcome:** Survived with rapid DCS approach [10][13]
- *Evidence: Real-world trauma protocol implementation*

***

### **SLIDE 29: Case Vignette #2 – When NOT to Use Permissive Hypotension**
**Scenario:** 68-year-old female, motor vehicle crash, blunt trauma, GCS 8, BP 92/54
- **Initial: SI = 92 ÷ 92 = 1.0** → Consider resuscitation
- **BUT: GCS 8 = severe TBI** → **DO NOT use permissive hypotension**
- **Modified approach:**
  - Target **MAP >100 mmHg** (age >50, TBI) [8][9]
  - Maintain **CPP >60 mmHg** (ICP monitoring if available) [8]
  - Use vasopressors (norepinephrine) to maintain perfusion [8]
- **Result:** Prevents secondary brain injury despite hemorrhage risk [8][9]
- *Evidence: Brain Trauma Foundation, TBI management guidelines*

***

### **SLIDE 30: Summary: Integration into Daily Practice**
| **Concept** | **Action** | **Evidence** |
|---|---|---|
| **xABCDE** | Prioritize hemorrhage control first | ATLS 11 [1][2][3] |
| **Shock Index >1.2** | Activate MTP immediately | PROPPR, shock physiology [5][1] |
| **Permissive HoTn** | SBP 80–100 **except TBI** | ATLS 11, BTF guidelines [6][8] |
| **TXA <1 hour** | Standard in all trauma MTP | CRASH-2 [16] |
| **DCS indications** | When physiology fails (temp <32°C, pH <7.15) | EAST, DCS meta-analysis [10][13] |
| **Timing re-op** | Individualize; delayed may reduce re-bleeding | 2025 meta-analysis [14] |

**BOTTOM LINE:** Modern trauma resuscitation = rapid hemorrhage control + balanced transfusion + metabolic stabilization, NOT aggressive crystalloid resuscitation.

***

## CHALK TALK (15–20 MIN, NO SLIDES)

### **Opening Case:**
"32-year-old male, gunshot wound to abdomen. Arrives with SBP 78/50, HR 132, pale. What do you do first?"

### **Teaching Block 1: What Changed with ATLS 11?**
- **Whiteboard draw:** Old ABCDE vs new xABCDE
- **Ask resident:** "What if he has active bleeding—do we intubate first?"
- **Answer:** If exsanguinating hemorrhage present, control that FIRST (direct pressure, tourniquet, OR)
- **Key concept:** xABCDE = hemorrhage control before airway (if life-threatening bleed)

### **Teaching Block 2: Shock Index in Real Time**
- **Whiteboard draw:** SI = HR/SBP
  - Calculate: 132 ÷ 78 = 1.69 → **Severe hemorrhage**
- **Ask:** "What do we do?" → **Activate MTP**
- **Why?** SI >1.2 predicts massive transfusion need, mortality [5]
- **Pulse Pressure:** 78 – (difficult to feel diastolic) → narrow → confirms shock

### **Teaching Block 3: Permissive Hypotension—But Not Always**
- **Scenario A:** Stab wound, no head injury → Permissive SBP 80–100 mmHg ✅
- **Scenario B:** Stab wound + GCS 8 (brain injury) → Maintain SBP >90 mmHg ❌
- **Why?** TBI needs perfusion (CPP 60–70 mmHg). Permissive HoTn worsens brain injury [8][9]
- **Ask resident:** "How do you know if there's a head injury?" → Neuro exam, CT brain

### **Decision Point #1: When to Go to OR?**
- **If SI persistent after 2L crystalloid + 2 units RBC** → **Go to OR for bleeding control**
- **DCS vs. definitive repair?** Depends on physiology:
  - Warm, normal pH, coagulation intact → Consider definitive repair [10]
  - Cool, acidotic, coagulopathic → DCS now, re-op later [10][13]

### **Teaching Block 4: Tranexamic Acid Timing**
- **Whiteboard draw timeline:**
  - **0–1 hour post-injury:** TXA gives 32% mortality reduction [16]
  - **1–3 hours:** Still beneficial (21% reduction) [16]
  - **>3 hours:** HARMFUL (increased thrombosis, mortality ↑) [16]
- **Mechanism:** Blocks fibrin breakdown (prevents fibrinolysis) [16][17]
- **Dose:** 1 g IV bolus + 1 g infusion over 8 hours [16]

### **Decision Point #2: Factor Concentrates or FFP?**
- **Scenario:** Coagulopathy on TEG (fibrinogen 80 mg/dL, PT 16)
- **Ask resident:** "Fibrinogen or FFP?"
  - **Answer:** Fibrinogen concentrate faster BUT **no mortality benefit** [21][20]
  - Reserve for **documented low fib** [21]
  - FFP works but slower [21]
- **rFVIIa?** NO – increased thromboembolism, worse outcomes [20]

### **Teaching Block 5: Planned Re-operation Timing**
- **Old dogma:** Re-op in 24–48 hours
- **New evidence (2025):** Delayed re-op (>48 h) **reduces re-bleeding without ↑ mortality** [14]
- **Whiteboard draw:** Two groups
  - **Early re-op:** More re-bleeding (12.4%)
  - **Delayed re-op:** Less re-bleeding (8.9%), same mortality [14]
- **Implication:** Let physiology recover (warm, coagulation normalized) before re-op [14]

### **Wrap-Up: Back to the Case**
"Your 32-year-old with GSW abdomen—SBP 78, SI 1.69, GCS 15:
1. **Activate MTP** (SI >1.2)
2. **Give TXA <1 hour** of injury
3. **Permissive hypotension** OK (no head injury, SBP 80–100 target)
4. **To OR** for hemorrhage control (DCS if unstable physiology)
5. **Plan re-op** based on recovery (not fixed 24–48 h)"

**Ask residents:**
- "If this patient had a GCS 7, what would change?" → Higher SBP target, ICU CPP targets
- "What if it's now 4 hours post-injury and he's acidotic?" → Consider DCS, but no late TXA

***

## ADDIE MICRO-CURRICULUM (Hemorrhage Control Fundamentals)

### **A - Analysis:**
- **Target learners:** PGY1–3 residents
- **Key knowledge gaps:** xABCDE algorithm, Shock Index application, MTP timing, TXA windows, when NOT to use permissive HoTn
- **Existing knowledge:** Basic ABCDE, BP assessment
- **Timeline:** 45–60 min (can split into 2 × 30 min sessions)

### **D - Design (Learning Objectives):**
By end of session, residents will:
1. **Apply xABCDE algorithm** with hemorrhage control prioritized (ATLS 11 standard)
2. **Calculate Shock Index** and use SI >1.2 as MTP trigger
3. **Implement permissive hypotension** appropriately (and identify exceptions like TBI)
4. **Administer TXA within optimal window** (<3 hours) with correct timing rationale
5. **Recognize DCS indications** and differentiate from definitive repair scenarios
6. **Individualize re-operation timing** based on physiology (not fixed timeline)

### **D - Development (Materials to Build):**
- Slide decks (SHORT/MEDIUM/LONG versions above)
- Printed pocket card: "xABCDE Quick Reference"
- Whiteboard diagrams (template below)
- Case vignettes (2 provided above; create 2 more for local trauma patterns)
- TEG/ROTEM interpretation guide (for coagulopathy)

### **I - Implementation:**
| **Week** | **Format** | **Duration** | **Content** |
|---|---|---|---|
| **Week 1** | Lecture + chalk talk | 30 min | xABCDE, Shock Index, MTP triggers |
| **Week 2** | Journal club | 45 min | PROPPR trial (1:1:1 transfusion) + CRASH-2 (TXA) |
| **Week 3** | Case-based learning | 60 min | 3 case vignettes (permissive HoTn exception, DCS timing, re-op planning) |
| **Week 4** | Simulation debrief | 30 min | Trauma activation with xABCDE protocol |

### **E - Evaluation:**
**Knowledge checks:**
- "SI = 1.4 in 35-year-old with no head injury. What's your SBP target?" → Answer: 80–100 mmHg ✓
- "Patient is 6 hours post-injury, acidotic, hypothermic. Give TXA?" → Answer: NO (>3h window) ✓

**Skills observation:**
- ✓ Resident calculates Shock Index correctly
- ✓ Activates MTP at SI >1.2
- ✓ Correctly identifies TBI exception to permissive HoTn

**Satisfaction survey:** Likert scale (1–5) on clarity, relevance, readiness to apply

***

***


***

***

